Discovery Research Programs

Diabetes And Heart Disease

Photo of Michael Farkouh

Program Leader: Dr. Michael Farkouh

The program connects multiple scientists and institutions from diverse disciplines/technology platforms to address the most challenging research questions in the prevention and treatment of cardiovascular complications of diabetes. This program’s main goal is to promote a Toronto-based, cross-site, clinical research collaboration on a central core platform. The initial focus will be on clinical trials in the following high impact research areas: diastolic heart failure, coronary artery disease, peripheral arterial disease, and inflammatory biomarkers/novel compounds.

 


Group Members

Michael Farkouh (Program Leader)
Denice Feig
Richard Gilbert
Lawrence Leiter
Julie Lovshin
Muhammad Mamdani
John Parker
Bruce Perkins
Ravi Retnakaran 
Jacob Udell
Diane Wherrett
Bernard Zinman

Recent Program Activities

In 2013, the BBDC and the Heart & Stroke/Richard Lewar Centre of Excellence in conjunction with the Vice-Dean of Research and International Relations, Faculty of Medicine established a funding program to support research initiatives focusing on diabetes and heart disease. The purpose of this funding program is to foster bench to bedside translational research with a focus on innovation and first-in man clinical trials.

In 2014 we partnerned with AstraZeneca to introduce the AstraZeneca Impact Challenge Grant which will provide three $250,000 research grants over the next three years to address the prevalence of cardiovascular disease in patients with diabetes. For more information on this funding program and past recipients, click on the link below.

Funding Program

AstraZeneca Impact Challenge Grant - Cardiovascular/Diabetes